Teva Pharmaceuticals
TEVA
TEVA
576 hedge funds and large institutions have $14.7B invested in Teva Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 96 funds opening new positions, 192 increasing their positions, 189 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
576
Holders Change
+39
Holders Change %
+7.26%
% of All Funds
7.67%
Holding in Top 10
36
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+28.57%
% of All Funds
0.48%
New
96
Increased
192
Reduced
189
Closed
45
Calls
$727M
Puts
$402M
Net Calls
+$325M
Net Calls Change
+$2.16M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$1.81B |
| 2 |
DFO
Duquesne Family Office
New York
|
$198M |
| 3 |
BlackRock
New York
|
$1.11B |
| 4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
$860M |
| 5 |
PC
PointState Capital
New York
|
$298M |
Top Sellers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
$154M |
| 2 |
Millennium Management
New York
|
$144M |
| 3 |
SPC
Slate Path Capital
New York
|
$187M |
| 4 |
Neuberger Berman Group
New York
|
$648K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$48.8M |
